desmopressin acetate

(redirected from Minirin)
Also found in: Medical.

des·mo·pres·sin acetate

 (dĕs′mə-prĕs′ĭn)
n.
A synthetic analog of vasopressin used therapeutically as an antidiuretic and in the management of bleeding in individuals with some forms of hemophilia and von Willebrand disease.

[des(a)m(in)o-, lacking an amine group (des-, variant of de- + amino-) + (vaso)pressin.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
References in periodicals archive ?
Treatment and assessment of compliance: All patients were recommended to take oral desmopressin (0.2mg) before going to bed (Ferring Pharmaceutical Company, Sweden, trade name: minirin, 0.1mg/ tablet) based on behavioral interventions.
Ferring is focused on developing oral formulations for peptide drugs including the world's first orally active peptide, desmopressin (MINIRIN) and the fast dissolving lyophilisate (MINIRIN MELT).
Arzneimittel, Fachinformation MINIRIN Parenteral, 2011.